October 19, 2026

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today...

recent articles

San Jose, California -- OptraSCAN®, the leading On-Demand Digital Pathology solution provider will be demonstrating its patented PD-L1 companion research workbench using an Automated AI Toolset through a free webinar on 23rd April 2020....

Dr. Dan Peruzzi, stereology educator and staff scientist at MBF Bioscience, will be hosting an online question and answer session on unbiased stereology. Dr. Peruzzi will cover both theoretical and practical aspects regarding the use of...

Ft. Myers, Florida – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused testing services, announces that it has integrated Indica Labs enterprise-level HALO AP™ image analysis platform for Image Analysis,...

Pathologist Logs into OR Image Acquisition CLICK HERE for Dr. Krishnamurthy of MD Anderson Study Bedside Diagnostics for Breast Cancer in JAMA Contact CaliberID for Remote Demo Source:...

By Nicholas Chan, Director of Digital Pathology at Motic COVID-19 is here to stay. What can we do about it? It’s become increasingly likely over the last several months, with the world grinding to a halt from this pandemic, that COVID-19...

HALO® MASTERCLASS WEBINAR SERIES Indica Labs is excited to introduce our new HALO® Masterclass Webinar Series.  Each masterclass webinar will offer a deep dive into a specific module or capability within our HALO, HALO AI, HALO Link...

OR

platinum partners

gold partners

Silver Partners

Media Partners